What will the export scenario be by 2030?

Indian diagnostic manufacturers export widely today - depending on the size of the Indian IVD company, most Indian players ship to anywhere between 40 and 100 countries worldwide, spanning Asia, Africa, the Middle East, Latin America, and more.

- Sanjiv Das [e-mail]

raw materials.

That means incentives for companies to manufacture reagents, plastics, & electronic components in India, reducing our dependence on costly imports. ADMI is striving for policies that encourage the creation of local raw material vendors. We are also advocating for newer manufacturing sites & MedTech zones with shared facilities & infrastructure. We promote R&D collaborations to develop indigenous alternatives (for example, developing native enzyme production). In short, by correcting tax anomalies & establishing a local supply chain, we can reduce input costs. These efforts, combined with government support, will make Indian IVD products more cost-effective & globally competitive.

What will the export scenario be by 2030?

Indian diagnostic manufacturers export widely today - depending on the size of the Indian IVD company, most Indian players ship to anywhere between 40 and 100 countries worldwide, spanning Asia, Africa, the Middle East, Latin America, and more. In terms of value, India's overall medical device exports (which include diagnostic products) were approximately $3.8 billion in FY2023-24 (as per IBEF data), and IVD kits are a growing share of this total. Currently, Indian companies export a range of products, including immunoassay kits (for diseases such as HIV, hepatitis, and dengue), rapid test kits (for diseases like malaria and COVID-19), ELISA kits, molecular diagnostic tests (like TB PCR kits), and even some equipment (e.g., glucometers and small analysers). By 2030, I expect our export footprint to expand significantly - likely doubling or tripling from current levels. With India becoming a medtech manufacturing hub, export revenues from diagnostics could reach $5-6 billion or more by 2030 (with the proper policy support). The export destinations will also broaden - we aim to enter more developed markets in Europe and the Americas with high-quality, affordable products.